# Dabigatran Etexilate

NDC: 72603-239
Generic name: Dabigatran Etexilate
Labeler / Manufacturer: NorthStar RxLLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20251201

FDA application: ANDA207961

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-239"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-239
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5937f27-88c7-4c4a-801e-4c8945008982